Due to COVID-19 and current government guidance, UCL CTC staff continue to work remotely however we are beginning to have limited access to the office from 6th July 2020. Please continue to email the trial specific mailbox with any urgent queries. For paper CRF trials, please continue to copy and scan CRFs to the trial inboxes (remove all patient identifiers except Trial Number and Initials) until further notice.

 
Advanced
Trials portfolio
ARISTOTLE
A phase III trial comparing standard versus novel CRT as pre-operative treatment for MRI defined locally advanced rectal cancer
ARISTOTLE is a multicentre, phase III, randomised trial comparing standard neoadjuvant chemoradiotherapy (CRT) of oral capecitabine and radiotherapy versus standard CRT with the addition of irinotecan [...]
Area: Lower gastro-intestinal cancer
Phase: Phase III
Status: In follow-up (non-recruiting)
BACCHUS
A phase II Multicentre Open-label Randomised Study of Neoadjuvant Chemotherapy and Bevacizumab in Patients with MRI defined High-Risk Cancer of the Rectum
A Phase II, Multicentre, Open-label, Randomised Study of Neoadjuvant Chemotherapy and Bevacizumab in Patients with MRI defined High-Risk Cancer of the Rectum.
Area: Lower gastro-intestinal cancer
Phase: Phase II
Status:
EXCITE
Erbitux, Xeloda, Campto, Irradiation Then Excision for locally advanced rectal cancer (North West/North Wales Clinical Oncology Group-04 on behalf of the NCRI rectal cancer subgroup)
Area: Lower gastro-intestinal cancer
Phase: Phase II
Status:
PANTHER
AZD8931, an EGFR inhibitor, in combination with FOLFIRI: A Phase I/II study to determine the importance of schedule and activity in colorectal cancer
PANTHER is a phase I/II trial in patients with recurrent or metastatic colorectal cancer. Phase I has closed to recruitment. The phase II part of the study is a single arm trial of AZD8931 + FOLFIRI.
Area: Lower gastro-intestinal cancer
Phase: Phase I/II
Status: Closed
Streamline-C
Streamlining staging of colorectal cancer with Whole Body MRI
Multicentre comparison
Area: Lower gastro-intestinal cancer
Phase: Observational trials
Status: Closed
Streamline-L
Streamlining staging of lung cancer with Whole Body MRI
Multicentre comparison
Area: Lower gastro-intestinal cancer
Phase: Observational trials
Status: Closed
Contact Us
Cancer Research UK & UCL Cancer Trials Centre
University College London
90 Tottenham Court Road
London
W1T 4TJ

View map
Email:
ctc.enquiries@ucl.ac.uk
Telephone:
+44 (0)20 7679 9898 (General CTC Enquiries)
Fax:
020 7679 9899
University College London, Gower Street, London, WC1E 6BT +44 (0)20 7679 2000

Copyright © 2020 UCL | Disclaimer | Freedom of Information | Accessibility | Privacy | Cookies | Contact Us